Dr. Reddy’s Stock Jumps To Record After Analysts Cheer Cancer Drug Settlement
People chat in the lobby of Innovation Plaza building, on Dr. Reddy’s Laboratories Ltd. campus in Hyderabad. (Photographer: Prashanth Vishwanathan/Bloomberg)

Dr. Reddy’s Stock Jumps To Record After Analysts Cheer Cancer Drug Settlement

Most analysts have raised their target price for Dr. Reddy’s Laboratories Ltd. after the Hyderabad-based drugmaker settled its litigation with Celgene Corp. for patents for the generic version of a...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.